Satellos Bioscience Inc. Equity And Liabilities
Satellos Bioscience Inc. (MSLE) had Equity And Liabilities of $31.89 million as of 2025-12-31, per its 40-F filed 2026-03-27.
Financial Statements › Notes
ifrs-full:EquityAndLiabilities · last filed 2026-03-27
- 2024-12-31: Equity And Liabilities 73.02M CAD.
- 2023-12-31: Equity And Liabilities 44.30M CAD.
CAD
| Period end | Equity And Liabilities |
|---|---|
| 2024-12-31 | 73.02M CAD 40-F · filed 2026-03-27 |
| 2023-12-31 | 44.30M CAD 40-F · filed 2026-03-27 |
USD
| Period end | Equity And Liabilities |
|---|---|
| 2025-12-31 | $31.89M 40-F · filed 2026-03-27 |
| 2024-12-31 | $50.75M 40-F · filed 2026-03-27 |
| 2023-12-31 | $33.49M 40-F · filed 2026-03-27 |